EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Quality Assessment of Commercially Available Azithromycin Tablets in Dhamar City, Yemen: A Comparative Study

Neaf G. Al-Tayar, Hussein Hussein Al-Qasham, Husam Ali Al-Magrebi, Bassam Hamood Safee, Nuruddin Mohammed Al-Barati, Ali. H. AL-Osta, Najeeb N. M. Maglas, Kholood M. Al-Dhuraibi, Bushra S. Samer, Ahmed Abdulkareem Al-Sayqal

Thamar University Journal of Natural & Applied Sciences · 28.06.2026 · 11 (1)

DOI: 10.59167/wpgv0y53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thamar University Journal of Natural & Applied Sciences, online erschienen am 28.06.2026. Verfasst von Neaf G. Al-Tayar und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Azithromycin is a critically important macrolide antibiotic and is listed by the World Health Organization (WHO) as an essential medicine. However, this classification does not ensure the quality of marketed products, especially in regions with weak regulatory systems. Continuous evaluation of available formulations is therefore necessary to maintain therapeutic effectiveness and protect patient safety.

Objective

This study aimed to evaluate the in vitro quality of five commercially available azithromycin 500 mg tablet brands in Dhamar City, Yemen, and compare them with international pharmacopeial standards.

Methods

Five brands (coded A1–A5) were tested for physical characteristics, weight variation, hardness, friability, disintegration time, assay (active ingredient content), and dissolution profile. All procedures followed the guidelines of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), and Indian Pharmacopoeia (IP).

Results

All brands met pharmacopeial limits for weight variation, hardness, disintegration, and dissolution (each released more than 80% of azithromycin within 30 minutes). However, Brand A5 failed the assay test, containing only 77.1% of the labelled amount (USP acceptance range: 90–110%). Brand A1 also failed the friability test, as the tablets fully disintegrated and exceeded the acceptable weight loss limit of ≤1%.

Conclusion

Although four of the five brands met pharmacopeial standards, two substandard products were identified—one with a critically low active ingredient content and another with poor mechanical strength. These issues represent a serious public health concern. The results highlight the urgent need for stronger post-market surveillance and regulatory control in Yemen to prevent the distribution of ineffective or unsafe medicines.

Zitieren

APA

Al-Tayar, N. G., Al-Qasham, H. H., Al-Magrebi, H. A., Safee, B. H., Al-Barati, N. M., AL-Osta, A. H., Maglas, N. N. M., Al-Dhuraibi, K. M., Samer, B. S., & Al-Sayqal, A. A. (2026). In Vitro Quality Assessment of Commercially Available Azithromycin Tablets in Dhamar City, Yemen: A Comparative Study. Thamar University Journal of Natural & Applied Sciences, 11(1). https://doi.org/10.59167/wpgv0y53

Vancouver

Al-Tayar NG, Al-Qasham HH, Al-Magrebi HA, Safee BH, Al-Barati NM, AL-Osta AH, et al. In Vitro Quality Assessment of Commercially Available Azithromycin Tablets in Dhamar City, Yemen: A Comparative Study. Thamar University Journal of Natural & Applied Sciences. 2026;11(1). doi:10.59167/wpgv0y53

BibTeX
@article{AlTayar2026,
  author = {Al-Tayar, Neaf G. and Al-Qasham, Hussein Hussein and Al-Magrebi, Husam Ali and Safee, Bassam Hamood and Al-Barati, Nuruddin Mohammed and AL-Osta, Ali. H. and Maglas, Najeeb N. M. and Al-Dhuraibi, Kholood M. and Samer, Bushra S. and Al-Sayqal, Ahmed Abdulkareem},
  title = {In Vitro Quality Assessment of Commercially Available Azithromycin Tablets in Dhamar City, Yemen: A Comparative Study},
  journal = {Thamar University Journal of Natural & Applied Sciences},
  year = {2026},
  volume = {11},
  number = {1},
  doi = {10.59167/wpgv0y53}
}
Kostenlos starten →